Peripheral muscle force · COPD
1 finding from 1 review
Peripheral muscle endurance/fatigability · COPD
1 finding from 1 review
Thigh muscle size · COPD
1 finding from 1 review
Exercise capacity · COPD
1 finding from 1 review
Functional performance · COPD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Symptoms of dyspnoea · COPD
1 finding from 1 review
Health‐related quality of life · COPD
1 finding from 1 review
Minor adverse events assessed: related to intervention only (e.g. redness) · COPD
NMES showed no clear difference in minor adverse events assessed: related to intervention only (e.g.… compared with usual care (with or without sham NMES) (low certainty).
1 finding from 1 review
Deep vein thrombosis · participants at risk of venous thromboembolism
NMES showed no clear difference in total DVT compared with alternative prophylaxis (low certainty).
1 finding from 1 review
PE · participants at risk of venous thromboembolism
NMES showed no clear difference in PE compared with no prophylaxis (low certainty).
1 finding from 1 review
Total VTE · participants at risk of venous thromboembolism
NMES may leads to lower total VTE compared with no prophylaxis (low certainty).
1 finding from 1 review
Bleeding (major and minor) · participants at risk of venous thromboembolism
1 finding from 1 review
Deep vein thrombosis · participants at risk of venous thromboembolism
NMES may leads to higher total DVT compared with low‐dose heparin (low certainty).
1 finding from 1 review
Asymptomatic DVT · participants at risk of venous thromboembolism
NMES showed no clear difference in asymptomatic DVT compared with low‐dose heparin (low certainty).
1 finding from 1 review
Symptomatic DVT · participants at risk of venous thromboembolism
NMES showed no clear difference in symptomatic DVT compared with low‐dose heparin (low certainty).
1 finding from 1 review
PE · participants at risk of venous thromboembolism
1 finding from 1 review
Total VTE · participants at risk of venous thromboembolism
1 finding from 1 review
Bleeding (major and minor) · participants at risk of venous thromboembolism
1 finding from 1 review
Deep vein thrombosis · participants at risk of venous thromboembolism
NMES showed no clear difference in total DVT compared with dextran 40 (low certainty).
1 finding from 1 review
Asymptomatic DVT · participants at risk of venous thromboembolism
NMES showed no clear difference in asymptomatic DVT compared with alternative prophylaxis (low certainty).
1 finding from 1 review